Cetuximab +/- chemotherapy enhances dendritic cell-mediated phagocytosis of colon cancer cells and ignites a highly efficient colon cancer antigen-specific cytotoxic T-cell response in vitro.
Correale, P, Botta, C, Cusi, M G, Del Vecchio, M T, De Santi, M M, Gori Savellini, G, Bestoso, E, Apollinari, S, Mannucci, S, Marra, M, Abbruzzese, A, Aquino, A, Turriziani, M, Bonmassar, L, Caraglia, M, Tagliaferri, P
International journal of cancer 2012 Apr 01;130: 1577-89